Status:
RECRUITING
A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma
Lead Sponsor:
Beijing Friendship Hospital
Conditions:
Papillary Thyroid Carcinoma
Thermal Ablation
Eligibility:
All Genders
18+ years
Brief Summary
A prospective cohort of papillary thyroid carcinoma(PTC), patients who received thermal ablation in our hospital since February 2023 was established as the study object. Preoperative and postoperative...
Eligibility Criteria
Inclusion
- ①≥18 years old; ② Obtain informed consent; ③ Ultrasonography showed that malignant nodules were single, the maximum diameter of nodules was ≤1cm and the distance from the capsule was ≥2mm. ④ no lymph node metastasis or other extra-glandular metastasis in the neck; ⑤ PTC was confirmed by fine needle puncture pathology; ⑥ Patients who do not meet Article 3, who still strongly request thermal ablation while fully informing the patient of the risk of recurrence, and who have been clinically assessed to be technically capable of thermal ablation
Exclusion
- ① Pregnant or lactating patients; ② Patients with other malignant tumors and not suitable for ablation by clinical evaluation; ③ Patients who cannot tolerate surgery; ④ Patients with cognitive impairment and other conditions who cannot accurately fill in thyroid-related questionnaires.
Key Trial Info
Start Date :
February 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2028
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05962892
Start Date
February 1 2024
End Date
February 28 2028
Last Update
January 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Friendship Hospital
Beijing, China